Attention to Bone Health in Follow-up of Gynaecological Cancers in Tertiary Care

Overview

Journal Womens Health (Lond)

Specialty Gynecology & Obstetrics

Date 2022 Jan 7

PMID 34994250

Citations 4

Authors

Catherine A OGorman

Sorcha Minnock

Joseph Mulhall

Noreen Gleeson

Affiliations

Soon will be listed here.

Abstract

Objective: Women with gynaecological cancers are at an increased risk of cancer treatment-induced bone loss, which impacts on their quality of life and overall survival. Clinical cancer follow-up reviews focus on cancer status and fail to attend to important health and quality-of-life issues. We questioned whether there was a care-gap between tertiary clinicians and primary care physicians in the management of bone health in this cohort. Significant care-gaps in relation to bone health have been demonstrated in other oncologic settings. The objective of this study was to determine the level of attention to bone health in the care of women living with and beyond gynaecological cancer at a tertiary referral centre for gynaecological oncology.

Methods: Retrospective, observational cohort study of attention to bone health in the management and follow-up of gynaecological cancers.

Results: This study shows that there has been suboptimal attention from the carers at a cancer centre to bone health during the oncological follow up of women undergoing treatment for gynaecological cancer. In those at particular risk of cancer treatment-induced bone loss (iatrogenic menopause and/or external beam pelvic radiotherapy), 52% of women had no reference to bone health in their notes, and 57% had no assessment of bone mineral density.

Conclusion: Tertiary cancer carers may underestimate the importance of bone health or believe that it falls outside the remit of their gynaecologic oncology service. Further research is needed to explore whether these findings are indicative of a true care gap and to gain insight into possible corrective measures.

Citing Articles

Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).

Perrucci E, Macchia G, Cerrotta A, Andrulli A, Autorino R, Barcellini A Radiol Med. 2024; 129(9):1329-1351.

PMID: 39198369 PMC: 11379782. DOI: 10.1007/s11547-024-01844-5.

Long Axial Field-of-View PET/CT Could Answer Unmet Needs in Gynecological Cancers.

Triumbari E, Rufini V, Mingels C, Rominger A, Alavi A, Fanfani F Cancers (Basel). 2023; 15(9).

PMID: 37173874 PMC: 10177015. DOI: 10.3390/cancers15092407.

Sarcopenia: Body Composition and Gait Analysis.

Fan Y, Zhang B, Huang G, Zhang G, Ding Z, Li Z Front Aging Neurosci. 2022; 14:909551.

PMID: 35912078 PMC: 9326397. DOI: 10.3389/fnagi.2022.909551.

Accuracy of Opportunistic Bone Mineral Density Assessment on Staging Computed Tomography for Gynaecological Cancers.

OGorman C, Milne S, Lambe G, Sobota A, Beddy P, Gleeson N Medicina (Kaunas). 2021; 57(12).

PMID: 34946331 PMC: 8703431. DOI: 10.3390/medicina57121386.

References

DOronzo S, Stucci S, Tucci M, Silvestris F . Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications. Cancer Treat Rev. 2015; 41(9):798-808. DOI: 10.1016/j.ctrv.2015.09.003. View

Sapienza L, Salcedo M, Ning M, Jhingran A, Klopp A, Calsavara V . Pelvic Insufficiency Fractures After External Beam Radiation Therapy for Gynecologic Cancers: A Meta-analysis and Meta-regression of 3929 Patients. Int J Radiat Oncol Biol Phys. 2019; 106(3):475-484. DOI: 10.1016/j.ijrobp.2019.09.012. View

Harvey N, McCloskey E, Mitchell P, Dawson-Hughes B, Pierroz D, Reginster J . Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures. Osteoporos Int. 2017; 28(5):1507-1529. PMC: 5392413. DOI: 10.1007/s00198-016-3894-y. View

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

Salcedo M, Sood A, Jhingran A, Eifel P, Klopp A, Iyer R . Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer. 2020; 126(11):2607-2613. PMC: 7220839. DOI: 10.1002/cncr.32807. View

Zhumkhawala A, Gleason J, Cheetham T, Niu F, Loo R, Dell R . Osteoporosis management program decreases incidence of hip fracture in patients with prostate cancer receiving androgen deprivation therapy. Urology. 2013; 81(5):1010-5. DOI: 10.1016/j.urology.2012.11.066. View

Grant W, Mohr S . Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann Epidemiol. 2009; 19(7):446-54. DOI: 10.1016/j.annepidem.2008.12.014. View

Spangler L, Yu O, Loggers E, Boudreau D . Bone mineral density screening among women with a history of breast cancer treated with aromatase inhibitors. J Womens Health (Larchmt). 2013; 22(2):132-40. PMC: 3573722. DOI: 10.1089/jwh.2012.3687. View

Hauser K, Walsh D, Shrotriya S, Karafa M . Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg?. Support Care Cancer. 2014; 22(7):1931-9. DOI: 10.1007/s00520-014-2154-y. View

10.

Shapiro C, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R . Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. J Clin Oncol. 2019; 37(31):2916-2946. DOI: 10.1200/JCO.19.01696. View

11.

Salminen H, Piispanen P, Toth-Pal E . Primary care physicians' views on osteoporosis management: a qualitative study. Arch Osteoporos. 2019; 14(1):48. PMC: 6486622. DOI: 10.1007/s11657-019-0599-9. View

12.

Martin-Herranz A, Salinas-Hernandez P . Vitamin D supplementation review and recommendations for women diagnosed with breast or ovary cancer in the context of bone health and cancer prognosis/risk. Crit Rev Oncol Hematol. 2015; 96(1):91-9. DOI: 10.1016/j.critrevonc.2015.05.006. View

13.

Tang B, Eslick G, Nowson C, Smith C, Bensoussan A . Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007; 370(9588):657-66. DOI: 10.1016/S0140-6736(07)61342-7. View

14.

Rizzoli R, Body J, Brandi M, Cannata-Andia J, Chappard D, Maghraoui A . Cancer-associated bone disease. Osteoporos Int. 2013; 24(12):2929-53. PMC: 5104551. DOI: 10.1007/s00198-013-2530-3. View

15.

Hadji P, Gnant M, Body J, Bundred N, Brufsky A, Coleman R . Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention?. Cancer Treat Rev. 2012; 38(6):798-806. DOI: 10.1016/j.ctrv.2012.02.008. View

16.

McCallum M, Jolicoeur L, Lefebvre M, Babchishin L, Robert-Chauret S, Le T . Supportive care needs after gynecologic cancer: where does sexual health fit in?. Oncol Nurs Forum. 2014; 41(3):297-306. DOI: 10.1188/14.ONF.297-306. View

17.

Hadjidakis D, Kokkinakis E, Sfakianakis M, Raptis S . The type and time of menopause as decisive factors for bone mass changes. Eur J Clin Invest. 1999; 29(10):877-85. DOI: 10.1046/j.1365-2362.1999.00541.x. View

18.

Nishio K, Tanabe A, Maruoka R, Nakamura K, Takai M, Sekijima T . Bone mineral loss induced by anticancer treatment for gynecological malignancies in premenopausal women. Endocr Connect. 2013; 2(1):11-7. PMC: 3680962. DOI: 10.1530/EC-12-0043. View

19.

Otmar R, Reventlow S, Nicholson G, Kotowicz M, Pasco J . General medical practitioners' knowledge and beliefs about osteoporosis and its investigation and management. Arch Osteoporos. 2012; 7:107-14. DOI: 10.1007/s11657-012-0088-x. View

20.

Wilson S, Sharp C, Davie M . Health-related quality of life in patients with osteoporosis in the absence of vertebral fracture: a systematic review. Osteoporos Int. 2012; 23(12):2749-68. DOI: 10.1007/s00198-012-2050-6. View